코렌텍

104540KOSDAQ의료용 기기 제조업

56.5 / 100

Reference Date: 2026-04-13

Financial Score26.0 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but Revenue metrics are weak. Declined 6.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Corentec is South Korea's first specialized manufacturer of artificial joints, established in 2000, and holds proprietary design and surface treatment technologies, including the world's first application of 3D printing in artificial joint production. Its main products, artificial hip and knee joints, account for over 84% of revenue, with ongoing R&D in spinal fixation devices and shoulder joints. The company operates global subsidiaries, including Corentec America and Corentec China, for artificial joint sales in key markets.

Number of Employees

181people

Average Salary

48.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.24Industry Average 26.528.0Point

Half of industry avg (excellent)

PBR

0.80Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE

8.03Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

14.73Industry Average 10.952.0Point

Higher than industry avg (caution)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.5% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲44.7% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 4.3% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 5,580Won52-week high 7,16052-week low 4,980

1-month return2.0Point

1m -6.69% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral정기주주총회결과2026-03-27
Neutral[기재정정]주주총회소집공고2026-03-24
Neutral[기재정정]주주총회소집결의2026-03-24
Neutral감사보고서제출2026-03-19
Neutral사업보고서 (2025.12)2026-03-19